This MicroStrategy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

BenzingaJan 29 09:55 ET

Truist Financial Initiates Larimar Therapeutics(LRMR.US) With Buy Rating, Announces Target Price $18

Moomoo NewsJan 29 08:31 ET · Ratings

Truist Sees 'Significant Upside' for Larimar Therapeutics, Starts With a Buy

TipRanksJan 29 06:40 ET · Ratings

Truist Initiates Larimar Therapeutics at Buy With $18 Price Target

MT NewswiresJan 29 06:21 ET · Ratings

Larimar Therapeutics Aligns Executive Incentives With Milestones

TipRanksJan 27 16:33 ET

Larimar Therapeutics Analyst Ratings

BenzingaJan 24 07:00 ET · Ratings

H.C. Wainwright Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsJan 24 06:31 ET · Ratings

Larimar Therapeutics' Promising Developments and Strategic Positioning Signal Buy Opportunity

TipRanksJan 23 18:25 ET

Express News | Larimar Therapeutics Inc - to Initiate Cohort of Children 2-11 Years Old in 1H 2025

ReutersJan 23 16:05 ET

Express News | Larimar Therapeutics Announces Dosing of Adolescents in Nomlabofusp Pediatric Pharmacokinetic Run-in Study for Patients With Friedreich’s Ataxia

ReutersJan 23 16:05 ET

Larimar Therapeutics Announces Dosing of Adolescents in Nomlabofusp Pediatric Pharmacokinetic Run-In Study for Patients With Friedreich's Ataxia

GlobeNewswireJan 23 16:05 ET

Solid Biosciences Stock Jumps 11% Post-market on FDA Update

Seeking AlphaJan 7 17:23 ET

Bullish Larimar Therapeutics Insiders Loaded Up On US$522.0k Of Stock

Yahoo FinanceJan 6 08:37 ET

JMP Securities Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $21

Moomoo NewsDec 20, 2024 13:31 ET · Ratings

Baird Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Cuts Target Price to $13

Moomoo NewsDec 17, 2024 11:31 ET · Ratings

Oppenheimer Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $26

Moomoo NewsDec 17, 2024 08:31 ET · Ratings

We're Hopeful That Larimar Therapeutics (NASDAQ:LRMR) Will Use Its Cash Wisely

Simply Wall StDec 17, 2024 08:04 ET

A Quick Look at Today's Ratings for Larimar Therapeutics(LRMR.US), With a Forecast Between $14 to $36

Moomoo NewsDec 17, 2024 08:00 ET · Ratings

12 Health Care Stocks Moving In Monday's Pre-Market Session

BenzingaDec 16, 2024 16:05 ET

Analyst Recommends Buy on Larimar Therapeutics Amid Misinterpreted Data and Overreaction

TipRanksDec 16, 2024 15:35 ET